Nexus Surgical appoints Ashish Durgaprasad Mishra as Independent Director
- Ashish Durgaprasad Mishra appointed as Independent Non-Executive Director
- Term spans five years from September 2, 2026 to September 1, 2031
- Appointment approved at the 35th Annual General Meeting on September 25, 2026
- Director holds DIN 10014935 and is unrelated to existing KMPs

*this image is generated using AI for illustrative purposes only.
Nexus Surgical and Medicare Limited has appointed Ashish Durgaprasad Mishra as an Independent Non-Executive Director. The appointment is effective from September 2, 2026, for a term of five years.
The decision was ratified by members during the company's 35th Annual General Meeting held on September 25, 2026, via video conferencing. The new director will serve until September 1, 2031.
Profile and Governance Details
Mishra brings expertise in financial statement analysis, forecasting, and risk management. His profile highlights a deep understanding of industry market trends, competitive dynamics, and regulatory frameworks, aimed at enhancing oversight and governance within the company.
The disclosure confirms that Mishra is not related to any existing Director or Key Managerial Personnel of the company. Furthermore, he is not debarred from holding the office of Director by any SEBI order or other authority, nor is he disqualified under Section 164 of the Companies Act, 2013.
Appointment Specifics
| Detail | Information |
|---|---|
| Name | Ashish Durgaprasad Mishra |
| Role | Independent Non-Executive Director |
| Term Start | September 2, 2026 |
| Term End | September 1, 2031 |
| Duration | 5 years |
The appointment was disclosed to BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Historical Stock Returns for Nexus Surgical & Medicare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.23% | -5.16% | -4.51% | +82.68% | +91.09% | +1,105.66% |
How will Ashish Durgaprasad Mishra's expertise in risk management specifically influence Nexus Surgical's upcoming capital allocation strategies?
What impact might this board appointment have on the company's compliance posture regarding evolving SEBI governance regulations?
Could Mishra's background in financial forecasting lead to revised earnings guidance or strategic pivots in the next fiscal quarter?


































